PriveBio is a precision medicine biotech focused on developing first-in-class therapeutics targeting metabolic dysfunction and fibro-inflammation in cardiorenal metabolic diseases (obesity, heart failure, NASH/MASH, and chronic kidney diseases), prosecuting validated targets from human proteo-genomics data across very large human datasets.
Company Details
- Employees
- 2
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.privebio.com
- Keywords
- Boston.
Privebio Questions
Privebio's website is http://www.privebio.com
Privebio's LinkedIn profile is https://www.linkedin.com/company/privebio
Privebio has
2 employees.
View email and phone details for 2
employees at Privebio.
Privebio's industry is
Biotechnology Research
Privebio's top competitors are
Apollo Health Ventures,
Tevogen Bio,
Larkspur Biosciences,
Incendia Therapeutics,
Brighter Ventures,
Marengo Therapeutics,
Normunity,
Hc Bioscience, Inc.,
Myracle Therapeutics,
Cytovia Therapeutics.
Privebio's categories are Biotechnology Research
